Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Diurnal Group Plc
Life Sciences
Unexpected Phase III trial outcome
17 Oct 2018
Advanced Oncotherapy
Life Sciences
Four components integrated
By
Dr Martin Hall
16 Oct 2018
Stay up-to-date with the latest research
Sign up to our newsletter
City of London Investment Group
Financials
Solid FUM update offset by margin changes
By
Dr Brian Moretta
09 Oct 2018
Burford Capital
Financials
Equity issue ensures growth is not adjourned
By
Dr Brian Moretta
05 Oct 2018
Building & Construction
UK Housebuilding Sector in 3Q 2018……trains, cows and beyond
05 Oct 2018
Warpaint London
Consumer
1H’18 interims: delivering the results
By
Yingheng Chen
04 Oct 2018
Diurnal Group Plc
Life Sciences
First commercial revenues
By
Dr Martin Hall
04 Oct 2018
The Monthly: October 2018
03 Oct 2018
Redx Pharma
Life Sciences
Strategy launch
By
Dr Martin Hall
02 Oct 2018
Palace Capital
Property
Initiation of coverage
By
Mike Foster
28 Sep 2018
Allergy Therapeutics plc
Life Sciences
2018 full-year results: solid growth
By
Dr Martin Hall
27 Sep 2018
Prev
1
...
58
59
60
61
62
...
78
Next
